national shortage of semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s The Food and Drug Administration

To view or add a comment, sign in Insulin Is Not the Last OptionIt Is the Right Option When Indicated It feels refreshing to return to one of the most important topics in everyday clinical practice that is Diabetes Mellitus Diabetes management should be simplified, not complicated by myths, fear, or misinformation

Youll also receive a personalized quote and a plan that fits your schedule

Continue hydrocortisone if needed

With the global semaglutide market projected to reach USD 93.6 billion by 2035 and the 2026 patent expiry window now open, securing a reliable, compliant semaglutide injection manufacturer in India in 2026 is a board-level priority for any importer or distributor in the GLP-1 space

Variants in the GLP1R gene (such as rs6923761), GIPR gene (rs1800437), FTO gene (rs9939609), and MC4R gene (rs17782313) affect appetite regulation, satiety signaling, and metabolic rate

And that combination will set you up to fuel your body better than a sugary doughnut would